As AMPK plays an important role in lots of cell‐signaling pathways,16, 17 it could be an ideal therapeutic target for the treatment of obesity, insulin resistance, type 2 diabetes, and cancer.38, 39. Here, PRKAA1 is linked to obesity due to melanocortin 4 receptor deficiency.